{"article_id": "IQV_q3_2020.txt", "article": ["we 've added 45 oce clients this year , bringing our total number of clients to 125 .", "revenue for the third quarter came in at $ 2,786 million , which was $ 11 million above the high end of our guidance range .", "third quarter adjusted ebitda was $ 604 million with a $ 22 million beat versus the high end of our guidance range .", "third quarter adjusted diluted earnings per share was $ 1.63 reflecting the ebitda drop - through because the below the line items essentially netted out to zero .", "third quarter r&ds contracted backlog , including pass - throughs , grew 18.5 % year - over - year to $ 21.7 billion as of september 30th , 2020 .", "the contracted net book - to - bill ratio , including pass - throughs , was 1.71 for the third quarter of 2020 and 1.42 excluding pass - throughs .", "the ltm contracted book - to - bill ratio at september 30 was 1.55 , including pass - throughs and 1.45 , excluding pass - throughs .", "third quarter revenue of $ 2,786 million grew 0.6 % reported and was flat at constant currency .", "revenue for the first nine months of the year was $ 8,061 million which was down 1.6 % reported and 1.2 % at constant currency .", "technology & analytics solutions revenue of $ 1,207 million grew 10.2 % reported and 9.2 % at constant currency .", "year - to - date tech & analytics solutions revenue was $ 3,433 million , up 4.9 % reported and 5.6 % at constant currency .", "in r&d solutions third quarter revenue of $ 1,400 million was down 4.5 % at actual fx rate and 5.1 % at constant currency .", "excluding the impact of pass - throughs , r&d solutions third quarter revenue grew 2.6 % .", "year - to - date revenue of $ 4,076 million was down 5.6 % at actual fx rate and 5.4 % at constant currency .", "contract sales & medical solutions revenue of $ 179 million was down 13.9 % year - over - year reported and 14.4 % on a constant currency basis in the third quarter .", "year - to - date revenue was $ 552 million , down 8.6 % at actual fx rates and 8.3 % at constant currency .", "now moving down to p&l , adjusted ebitda was $ 604 million for the third quarter , which represented growth of 1.9 % .", "year - to - date adjusted ebitda was $ 1,649 million .", "third quarter gaap net income was $ 101 million and gaap diluted earnings per share was $ 0.52 .", "year - to - date gaap net income was $ 160 million and gaap diluted earnings per share was $ 0.82 .", "adjusted net income was $ 318 million for the quarter and $ 841 million year - to - date .", "our adjusted diluted earnings per share grew 1.9 % in the third quarter to $ 1.63 .", "year - to - date adjusted diluted earnings per share was $ 4.32 .", "consequent on the robust booking activity that ari talked about , our backlog grew 18.5 % year - over - year to close at $ 21.7 billion and we expect $ 5.8 billion of this backlog to convert to revenue over the next 12 months , which is an increase of over $ 400 million versus where we were at june 30th .", "at september 30th , cash and cash equivalents totaled $ 1.5 billion and debt was $ 12.3 billion , resulting in net debt of $ 10.9 billion .", "due to our strong ebitda and cash flow in the quarter , our net leverage ratio at september 30th was 4.7 times trailing 12 - month adjusted ebitda , which was down a tad [ phonetic ] from where we were at june 30th .", "cash flow from operations was $ 574 million in the third quarter , up 74 % over last year .", "capital expenditures were $ 157 million and that resulted in free cash flow of $ 417 million .", "for the first nine months of the year , free cash flow was $ 769 million , which is about double the same period last year .", "underlying demand is robust and cash flow is as well and we have a very solid liquidity position closing the quarter with an undrawn revolver of almost -- undrawn revolver and almost $ 1.5 billion of cash in the balance sheet .", "and as a reminder , we currently have about $ 1 billion of share repurchase authorization remaining under the program .", "we now expect 2020 revenue for the full year to be between $ 11,100 million and $ 11,250 million , which is an increase of $ 125 million over our prior guidance at the midpoint of the range .", "for profit we now expect full - year adjusted ebitda to be between $ 2,335 million and $ 2,360 million , which represents a $ 27 million increase over our prior guidance at the midpoint of the range .", "and adjusted diluted eps , we are expecting to be between $ 6.25 and $ 6.35 , which is an increase of $ 0.10 over our prior guidance at the midpoint of the range .", "this full - year guidance implies fourth quarter revenue of $ 3,040 million to $ 3,190 million , representing growth of 5 % to 10.2 % .", "for fourth quarter profit , we expect adjusted ebitda to be between $ 685 million and $ 710 million , representing growth of 6.7 % to 10.6 % and adjusted diluted earnings per share to be between $ 1.93 and $ 2.03 , or growth of 10.9 % to 16.7 % .", "for the full year 2021 , we expect revenue in the range of $ 12,300 million to $ 12,600 million .", "this represents growth of 10.1 % to 12.8 % versus the midpoint of our 2020 guide .", "we expect adjusted ebitda to be in the range of $ 2,725 million to $ 2,800 million , representing growth of 16.1 % to 19.3 % compared to the midpoint of our 2020 guidance .", "and finally , we expect adjusted earnings per share to be in the range of $ 7.65 to $ 7.95 , which would represent growth of 21.4 % to 26.2 % compared to the midpoint of our 2020 guidance .", "the adjusted diluted earnings per share guidance assumes interest expense of approximately $ 420 million , operational depreciation and amortization of about $ 400 million and other below the line expense items such as minority interest of approximately $ 50 million and also the continuation of our share repurchase activity ."], "summary_gold": "q3 adjusted earnings per share $ 1.63 .<q>q3 gaap earnings per share $ 0.52 .<q>sees fy 2020 revenue $ 11,100 million - $ 11,250 million .<q>sees fy 2020 adjusted earnings per share $ 6.25 - $ 6.35 .<q>lifting temporary suspension of its share repurchase program .<q>for full year of 2021 , expects revenue of between $ 12,300 million and $ 12,600 million .<q>for fy 2021 , sees adjusted earnings per share of between $ 7.65 and $ 7.95 .", "summary_pred": "our adjusted diluted earnings per share grew 1.9 % in the third quarter to $ 1.63 .<q>year - to - date revenue of $ 4,076 million was down 5.6 % at actual fx rate and 5.4 % at constant currency .<q>we now expect 2020 revenue for the full year to be between $ 11,100 million and $ 11,250 million , which is an increase of $ 125 million over our prior guidance at the midpoint of the range .<q>and as a reminder , we currently have about $ 1 billion of share repurchase authorization remaining under the program .<q>underlying demand is robust and cash flow is as well and we have a very solid liquidity position closing the quarter with an undrawn revolver of almost -- undrawn revolver and almost $ 1.5 billion of cash in the balance sheet .<q>third quarter r&ds contracted backlog , including pass - throughs , grew 18.5 % year - over - year to $ 21.7 billion as of september 30th , 2020 .<q>third quarter adjusted ebitda was $ 604 million with a $ 22 million beat versus the high end of our guidance range .<q>capital expenditures were $ 157 million and that resulted in free cash flow of $ 417 million .<q>we 've added 45 oce clients this year , bringing our total number of clients to 125 .", "len_article": 41, "len_summary_gold": 7, "len_summary_pred": 9, "len_sent_scores": 41}